New blood test for diagnosing infected necrosis in severe pancreatitis
Part of Digestive system clinical trials.
This study tests a new blood test that looks for signs of infection in people with severe pancreatitis. It aims to more accurately detect if the dead pancreatic tissue has become infected, which could help doctors decide on treatment earlier.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have confirmed acute necrotizing pancreatitis (a severe form of pancreatitis) with symptoms starting within the last 48 hours.
- You must be at least 14 years old.
- You must not have had any drainage or surgery for this condition before joining the study.
- You must not have an infection outside the pancreas, such as pneumonia or a urinary tract infection.
- You cannot be pregnant.
- You must not have a history of recurrent acute pancreatitis.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial collects blood samples from people with infected pancreatic necrosis to find patterns that help diagnose the condition. The goal is to reduce the need for invasive tests and start treatment faster.
This study looks at how organ function changes in people with severe acute pancreatitis who also have sepsis, after surgery to remove infected dead tissue from the pancreas. If you're having this type of surgery, the study hopes to improve understanding of recovery and organ health.
This study looks at specific blood markers during an acute pancreatitis episode to better understand the condition. It may help improve treatment for future patients.
This study looks at specific blood “immune” signatures and how they relate to outcomes in people with acute pancreatitis. If you enroll early, it may help doctors better predict how the illness will go and identify who might need more care.
This study looks at how a surgery to remove dead tissue from the pancreas (called open necrosectomy) affects organ function in patients with acute pancreatitis and sepsis. It may help doctors understand how to better treat this serious condition.
This trial tests a new blood test to measure how well your pancreas works. It may help people with chronic pancreatitis understand their condition and quality of life.
Hear when a new Acute Necrotizing Pancreatitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.